IDEX Health & Science LLC designs, develops, and manufactures liquid subassemblies and precision components for a wide range of applications requiring precise control and measurement.
Company Description
IDEX Health & Science LLC designs, develops, and manufactures liquid subassemblies and precision components for a wide range of applications requiring precise control and measurement. We specialize in component integration that results in innovative and optimized OEM fluidic systems. IDEX Health & Science is the synthesis of leading component and technology suppliers to the analytical instrumentation, in vitro diagnostics, biotechnology, and laboratory markets. Our brands include Eastern Plastics, Innovadyne, Ismatec, Isolation Technologies, Rheodyne, Sapphire Engineering, Systec, and Upchurch Scientific.
Chief Chromatographic Techniques Supported
Markets Served
Major Products/Services
Facilities
Manufacturing facilities in North America and Asia. Class 1,000, 10,000, and 100,000 clean rooms.
IDEX Health & Science LLC
619 Oak Street
Oak Harbor, WA 98277
TELEPHONE
(866) 339-4653
FAX
(360) 682-4151
WEB SITE
Investigating 3D-Printable Stationary Phases in Liquid Chromatography
May 7th 20253D printing technology has potential in chromatography, but a major challenge is developing materials with both high porosity and robust mechanical properties. Recently, scientists compared the separation performances of eight different 3D printable stationary phases.
Detecting Hyper-Fast Chromatographic Peaks Using Ion Mobility Spectrometry
May 6th 2025Ion mobility spectrometers can detect trace compounds quickly, though they can face various issues with detecting certain peaks. University of Hannover scientists created a new system for resolving hyper-fast gas chromatography (GC) peaks.
University of Oklahoma and UC Davis Researchers Probe Lipidomic Profiles with RP-LC–HRMS/MS
May 6th 2025A joint study between the University of Oklahoma Health Sciences Center (Oklahoma City, Oklahoma) and the UC Davis West Coast Metabolomics Center (Davis, California) identified differentially regulated lipids in type 2 diabetes (T2D) and obesity through the application of reversed-phase liquid chromatography-accurate mass tandem mass spectrometry (RP-LC-accurate MS/MS).